CA2997744C — Compositions comprising mixtures of semifluorinated alkanes
Assigned to Novaliq GmbH · Expires 2019-12-31 · 6y expired
What this patent protects
The invention provides novel compositions comprising one or at least two or more semifluorinated-alkanes. The compositions can be used as medicines that are topically administered to an eye or ophthalmic tissue, such as for use in the treatment of keratoconjunctivitis sicca (dry …
USPTO Abstract
The invention provides novel compositions comprising one or at least two or more semifluorinated-alkanes. The compositions can be used as medicines that are topically administered to an eye or ophthalmic tissue, such as for use in the treatment of keratoconjunctivitis sicca (dry eye) and/or Meibomian gland dysfunction and symptoms associated therewith In one aspect, the invention provides a composition comprising one semi-fluorinated alkane that can be used to solubilize and remove abnormal and obstructive meibum from the eye of a patient. The invention further provides kits comprising such compositions.
Drugs covered by this patent
- Miebo (PERFLUOROHEXYLOCTANE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.